Imprimis NJOF, LLC recalls Tropicamide-Proparacaine-Phenylephrine-Ketorolac, Sterile Ophthalmic Solution, 1% 0.5% 2.5% 0.5%, 5mL, 2x5ML vial per carton, Rx Only,…

Sub-Potent Drug: Subpotent assay results during stability testing.

Date

2025-07-30

Country

United States

Brand

Imprimis NJOF

Product

Tropicamide-Proparacaine-Phenylephrine-Ketorolac, Sterile Ophthalmic Solution, 1% 0.5% 2.5% 0.5%, 5mL, 2x5ML vial per carton, Rx Only,…

Classification

Class III

Units

Nationwide in the USA

Category

Drugs & medical

Source

FDA · Drug

Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

1. Check the product name, strength and lot number against the official notice.
2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.

More Imprimis NJOF recalls

1. 2026-01-14
2. US
   Drugs & medicalClass II

   Imprimis NJOF, LLC recalls Tri-Moxi+¿ (Triamcinolone 9mg/0.6mL, Moxifloxacin 0.6 mg/ 0.6 mL) Single-Use Intraocular Injection, Imprimis NJOF, LLC., 1705 Route 46…

   Presence of particulate matter - Glass like particles.

   FDA · DrugImprimis NJOF, LLCU.S NationwideOfficial notice →
3. 2025-11-26
4. US
   Drugs & medicalClass III

   Imprimis NJOF, LLC recalls Klarity-C Drops (Cyclosporine) 0.1%, Preservative-Free Sterile Ophthalmic Emulsion, This is a compounded drug, Office Use Only, 5.5 mL…

   Subpotent Drug

   FDA · DrugImprimis NJOF, LLCUSA nationwideOfficial notice →
5. 2025-04-09
6. US
   Drugs & medicalClass III

   Imprimis NJOF, LLC recalls Tropicamide - Proparacaine - Phenylephrine - Ketorolac Sterile Ophthalmic Solution, 1% 0.5% 2.5% 0.5%, 5 mL fill in 15 mL bottle, Imprimis…

   Sub-Potent Drug: The stability batch showed a subpotent result, which does not meet the product specifications of 90.0-110.0% of the label claim.

   FDA · DrugImprimis NJOF, LLCFL and NYOfficial notice →
7. 2024-06-19
8. US
   Drugs & medicalClass II

   Imprimis NJOF, LLC recalls Prednisolone-Moxifloxacin-Bromfenac Sterile Ophthalmic Suspension, 1%, 0.5%, 0.075%, 5mL, Quantity: 20mL, Rx Only, Compounded by: Imprimis…

   Lack of Assurance of Sterility

   FDA · DrugImprimis NJOF, LLCUS NationwideOfficial notice →
9. 2024-06-05
10. US
    Drugs & medicalClass II

    Imprimis NJOF, LLC recalls Dexamethasone-Moxifloxacin- Ketorolac (1mg/mL, 0.5 mg/mL and 0.4 mg/mL), Preservative-Free, 1mL Single-Use vials for Intraocular…

    Lack of Assurance of Sterility

    FDA · DrugImprimis NJOF, LLCNationwide within the United StatesOfficial notice →
11. 2024-05-08
12. US
    Drugs & medicalClass III

    Imprimis NJOF, LLC recalls Epinephrine-Lidocaine HCl 0.25 mg/mL and 7.5 mg/mL Preservative-Free, 1 mL Single-Use vials, Rx only, Imprimis NJOF, LLC 1705 Route 46…

    Out of specification for assay

    FDA · DrugImprimis NJOF, LLCNationwide within the United StatesOfficial notice →

Other drugs & medical recalls in the United States

1. 2025-07-30
2. US
   Drugs & medicalClass II

   Cipla USA, Inc. recalls Budesonide Inhalation Suspension, 0.5mg/2ml, 30 single-dose ampules per carton, five per pouch, RX Only, Manufactured by: Cipla Ltd.…

   Lack of Assurance of Sterility: A market complaint was received for leakage and empty ampoule.

   FDA · DrugCipla USA, Inc.Distributed Nationwide in the USAOfficial notice →
3. US
   Drugs & medicalClass II

   Mckesson Medical-Surgical Inc. Corporate Office recalls EVENITY, (romosozumab -aqqg) injection, 105mg/1.17 mL, For Subcutaneous Use Only, Rx Only, Manufactured by:…

   CGMP Deviations; potential temperature excursions due to transit delays

   FDA · DrugMckesson Medical-Surgical Inc. Corporate OfficeWithin the U.S - OH, VA, FL.Official notice →
4. US
   Drugs & medicalClass II

   Lupin Pharmaceuticals Inc. recalls clomiPRAMINE Hydrochloride Capsules USP 25 mg, 100 count bottles, 5801 Pelican Bay Boulevard, Suite 500, Naples, Florida 34108, NDC#…

   Failed Impurities/Degradation Specifications: an out of specification result observed in degradation product test (any unspecified degradation product) during retention sample testing at expiry.

   FDA · DrugLupin Pharmaceuticals Inc.Nationwide.Official notice →
5. 2025-07-23
6. US
   Drugs & medicalClass II

   Medtronic, Inc. recalls Medtronic SmartLink Software loaded on SmartSync Patient Connector, Model Number 24967 with the following software components: 1. Azure…

   A software update for Medtronic CareLink SmartSync Device Manager (SmartSync) is now available. The update eliminates the potential display of an erroneous electrical reset (pop-up) message upon interrogation with a…

   FDA · DeviceMedtronic, Inc.WorldwideOfficial notice →
7. US
   Drugs & medicalClass II

   Encore Medical, LP recalls Brand Name: EMPOWR 3D KNEE TIBIAL INSERT - E-PLUS Product Name: EMPOWR 3D KNEETM INS, 11L 12MM, VE Model/Catalog Number: 341-12-711…

   Due to packaging discrepancy with the incorrect tibial inserts/implants being packaged. The use of this product may result in the incorrect product being selected. This could result in a revision surgery if used.

   FDA · DeviceEncore Medical, LPU.S Distribution to states of: AZ, IA, ID, IL, IN, LA, MI, MO, MS, NE, NY, OK,…Official notice →
8. US
   Drugs & medicalClass II

   Microbiologics Inc recalls KWIK-STIK and LYFO DISK, quality control kit for culture media Catalog # 0805K and 0805L

   Affected products contain Staphylococcus epidermidis instead of the expected Brevundimonas diminuta. This may cause the user's quality control to fail and delayed diagnosis for the patient.

   FDA · DeviceMicrobiologics IncUS distribution to states of: Utah and Ohio; and OUS (International) to…Official notice →